Terug
37
Ook genoteerd als
TCYMF
OTC
Dagbereik
€ 32,63
€ 33,85
52-Weeksbereik
€ 26,20
€ 37,30
Volume
452
50D / 200D Gem.
€ 32,34
/
€ 30,11
Vorige Slotkoers
€ 32,64
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Defensive sector mediaan (329 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 2,2 | 10,5 |
| P/B | 0,6 | 1,2 |
| ROE % | 30,0 | 12,3 |
| Net Margin % | 5,7 | 5,3 |
| Rev Growth 5Y % | 0,9 | 5,5 |
| D/E | 1,0 | 0,6 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,00
€ 0,00 – € 0,00
|
590 B | 0 |
| FY2026 |
€ 0,00
€ 0,00 – € 0,00
|
570 B | 0 |
Belangrijkste Punten
Revenue grew 0,94% annually over 5 years — modest growth
Earnings grew 17,24% over the past year
ROE of 29,97% indicates high profitability
Generating 4,66B in free cash flow
P/E of 2,17 — trading at a low valuation
PEG of 0,76 suggests growth is underpriced
Groei
Revenue Growth (5Y)
0,94%
Revenue (1Y)-4,63%
Earnings (1Y)17,24%
FCF Growth (3Y)94,05%
Kwaliteit
Return on Equity
29,97%
ROIC15,47%
Net Margin5,69%
Op. Margin8,11%
Veiligheid
Debt / Equity
1,02
Current Ratio0,72
Interest Coverage19,98
Waardering
P/E Ratio
2,17
P/B Ratio0,63
EV/EBITDA2,24
Dividend Yield0,06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4,63% | Revenue Growth (3Y) | -2,20% |
| Earnings Growth (1Y) | 17,24% | Earnings Growth (3Y) | 18,51% |
| Revenue Growth (5Y) | 0,94% | Earnings Growth (5Y) | 3,59% |
| Profitability | |||
| Revenue (TTM) | 76,91B | Net Income (TTM) | 4,38B |
| ROE | 29,97% | ROA | 7,96% |
| Gross Margin | 34,82% | Operating Margin | 8,11% |
| Net Margin | 5,69% | Free Cash Flow (TTM) | 4,66B |
| ROIC | 15,47% | FCF Growth (3Y) | 94,05% |
| Safety | |||
| Debt / Equity | 1,02 | Current Ratio | 0,72 |
| Interest Coverage | 19,98 | Dividend Yield | 0,06% |
| Valuation | |||
| P/E Ratio | 2,17 | P/B Ratio | 0,63 |
| P/S Ratio | 0,12 | PEG Ratio | 0,76 |
| EV/EBITDA | 2,24 | Dividend Yield | 0,06% |
| Market Cap | 9,52B | Enterprise Value | 13,94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 76,91B | 80,65B | 80,42B | 78,72B | 74,08B |
| Net Income | 4,38B | 3,73B | 3,12B | 2,63B | 3,80B |
| EPS (Diluted) | 15,60 | 13,20 | 11,00 | 9,40 | 13,60 |
| Gross Profit | 26,78B | 26,70B | 24,47B | 22,90B | 22,51B |
| Operating Income | 6,24B | 5,88B | 3,91B | 3,33B | 4,33B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 54,97B | 53,15B | 53,15B | 58,45B | 60,31B |
| Total Liabilities | 36,46B | 35,53B | 35,93B | 41,63B | 37,90B |
| Shareholders' Equity | 14,99B | 14,23B | 13,89B | 13,37B | 18,66B |
| Total Debt | 15,24B | 13,52B | 14,06B | 17,92B | 14,02B |
| Cash & Equivalents | 10,82B | 7,52B | 6,75B | 12,32B | 15,84B |
| Current Assets | 21,26B | 17,99B | 20,47B | 24,03B | 25,67B |
| Current Liabilities | 29,38B | 32,42B | 29,19B | 31,70B | 29,83B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#262 of 670
Recente Activiteit
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026